Cardiovascular biology: signalling silenced

Nature. 2003 Sep 11;425(6954):139-41. doi: 10.1038/425139a.
No abstract available

Publication types

  • News

MeSH terms

  • Endothelial Growth Factors / pharmacology
  • Humans
  • Intercellular Signaling Peptides and Proteins / pharmacology
  • Lymphokines / pharmacology
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases / metabolism
  • Neoplasms / blood supply
  • Neoplasms / drug therapy
  • Neovascularization, Physiologic* / drug effects
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Receptor, Fibroblast Growth Factor, Type 2
  • Receptors, Fibroblast Growth Factor / antagonists & inhibitors*
  • Receptors, Fibroblast Growth Factor / metabolism
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors*
  • Receptors, Vascular Endothelial Growth Factor / metabolism
  • Signal Transduction* / drug effects
  • Tissue Inhibitor of Metalloproteinase-2 / genetics
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism*
  • Tissue Inhibitor of Metalloproteinase-2 / pharmacology
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Matrix Metalloproteinase Inhibitors
  • Receptors, Fibroblast Growth Factor
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Tissue Inhibitor of Metalloproteinase-2
  • FGFR2 protein, human
  • Receptor Protein-Tyrosine Kinases
  • Receptor, Fibroblast Growth Factor, Type 2
  • Receptors, Vascular Endothelial Growth Factor
  • Matrix Metalloproteinases